Latest Leadership And Governance News

Mayfield Group Holdings has raised its fully franked final dividend to 2.2 cents per share for FY25, reflecting solid financial health and promising ongoing shareholder returns.

Invion Limited posted a $8.8 million loss for FY25, marking a 56.5% increase, while advancing clinical trials and securing fresh capital. The biotech faces a going concern warning amid ongoing development and funding challenges.

M3 Mining Limited has announced a significant leadership renewal alongside a strategic review aimed at streamlining operations, reducing costs, and focusing on high-value exploration assets.

WiseTech Global reported a robust FY25 with 14% revenue growth and a 17% rise in net profit, underpinned by a transformative $2.1 billion acquisition of e2open and strategic leadership changes.

Tabcorp Holdings Limited has reported a significant financial turnaround for FY25, driven by the new Victorian Wagering and Betting Licence and strategic operational improvements. The company posted $2.6 billion in revenue and a net profit after tax of $36.6 million, reversing last year's substantial loss.

McPherson’s Limited reported a 3.9% revenue decline to $139 million in FY25 amid a strategic shift to a pharmacy wholesaler model, posting a $15 million net loss but signaling moderate EBITDA growth ahead.

AdAlta Limited reported a reduced net loss of $4.5 million for FY2025 but flagged material uncertainty over its ability to continue as a going concern, with no dividends declared.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.

Integrated Research Limited reported an 18% revenue decline and a 51% drop in net profit for FY25, while unveiling a strategic pivot towards AI-driven product innovation and cloud services.

Pacific Current Group Limited reported a 3.3% decline in revenue and a 19% drop in underlying net profit after tax for FY25, alongside a major share buy-back and key portfolio restructurings.

Coles Group Limited reported modest growth in FY25 with $44.35 billion revenue and $1.08 billion net profit, underpinned by major supply chain investments and sustainability milestones. The company maintained dividends but faces ongoing legal challenges.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.